Cargando…

Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi

Detalles Bibliográficos
Autores principales:	Ginsburg, Amy Sarah, May, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228938/ https://www.ncbi.nlm.nih.gov/pubmed/34167590 http://dx.doi.org/10.1186/s41479-021-00089-4

Ejemplares similares

Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022)

Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)

Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis
por: Nkwopara, Evangelyn, et al.
Publicado: (2019)

Dexamethasone in community-acquired pneumonia
por: Lee, Nelson, et al.
Publicado: (2011)

Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2–59 Months with pneumonia, Kenya: A cluster randomized controlled trial
por: Angwa, Linet M., et al.
Publicado: (2020)

Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones
por: Carral, Nerea, et al.
Publicado: (2023)

Chest radiography in children aged 2–59 months enrolled in the Innovative Treatments in Pneumonia (ITIP) project in Lilongwe Malawi: a secondary analysis
por: Mvalo, Tisungane, et al.
Publicado: (2022)

Aetiological agents of community acquired pneumonia
por: Karabay, Oguz, et al.
Publicado: (2012)

Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Treatment of Severe Community-Acquired Pneumonia with Oral Amoxicillin in Under-Five Children in Developing Country: A Systematic Review
por: Das, Rashmi Ranjan, et al.
Publicado: (2013)

Evaluating the use of job aids and user instructions to improve adherence for the treatment of childhood pneumonia using amoxicillin dispersible tablets in a low-income setting: a mixed-method study
por: Sarma, Haribondhu, et al.
Publicado: (2019)

Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Non-adherence to oral antibiotics for community paediatric pneumonia treatment in Malawi – A qualitative investigation
por: King, Carina, et al.
Publicado: (2018)

Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens
por: Fabre, Valeria, et al.
Publicado: (2020)

Interchangeability of Two 500 Mg Amoxicillin Capsules with One 1000 Mg Amoxicillin Tablet After a Single Oral Administration
por: Zaid, A. N., et al.
Publicado: (2010)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Clinical and etiological characteristics of community-acquired pneumonia at high altitudes in Tibet, China
por: Meilang, Qucuo, et al.
Publicado: (2021)

Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidence
por: Chiang, Cho-Han, et al.
Publicado: (2023)

COVID-19 trial co-enrolment and subsequent enrolment
por: Gertner, Elie
Publicado: (2020)

Repeat assessment of examination signs among children in Malawi with fast-breathing pneumonia
por: Lenahan, Jennifer L., et al.
Publicado: (2020)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

Formulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets
por: Aslani, Abolfazl, et al.
Publicado: (2014)

Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019)

Aetiological spectrum of severe community-acquired pneumonia in HIV-positive patients from Pune, India
por: Mane, Arati, et al.
Publicado: (2018)

Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
por: Schuetz, Philipp
Publicado: (2020)

Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi
por: Aston, Stephen J., et al.
Publicado: (2019)

Community-acquired MRSA
por: Bloomfield, Sally F
Publicado: (2006)

Title Correction: Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019)

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)

Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis
por: McCollum, Eric D., et al.
Publicado: (2019)

2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Huttner, Benedikt, et al.
Publicado: (2020)

Management of Community-Acquired Pneumonia in Pediatrics: Adherence to Clinical Guidelines
por: Tannous, Rim, et al.
Publicado: (2020)

1132. Evaluating an Amoxicillin Dosing Regimen for Community Acquired Pneumonia: A Quality Improvement Initiative Using Clinical and Laboratory Data
por: Keeler, Emma, et al.
Publicado: (2021)

High Acceptability of an Orally Dispersible Tablet Formulation by Children
por: Wagner-Hattler, Leonie, et al.
Publicado: (2021)

Fast-breathing vs chest-indrawing childhood pneumonia: baseline characteristics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Understanding key drivers and barriers to implementation of the WHO recommendations for the case management of childhood pneumonia and possible serious bacterial infection with amoxicillin dispersible tablets (DT) in Bangladesh: a qualitative study
por: Rahman, Mahfuzur, et al.
Publicado: (2020)

Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets
por: Al-Tabakha, Moawia M., et al.
Publicado: (2017)

To the editor:: Community-acquired versus Nosocomial Klebsiella pneumonia Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
por: Vandijck, Dominique M, et al.
Publicado: (2007)

Severe community-acquired pneumonia caused by Panton-Valentine leukocidin-positive Staphylococcus aureus: first reported case in the United Kingdom
por: Klein, J. L., et al.
Publicado: (2003)

Tablet v. Tabloid
por: Razzak, Abdur
Publicado: (1917)

Cannot write session to /tmp/vufind_sessions/sess_q2bua6tudavsnvt8u4qdvikehr